Home About us Reports Charts News Custom Company Scan  
Report Charts News
Title Content
Life Sciences
  Metals & Minerals
Public Sector
  Finance Service
  Real Estate
Technology And Media

Tel: 0086-10-82600828
Fax: 0086-10-82601570

 Changshan Biochemical Pharmaceutical’s capacity of low molecular weight heparin calcium injection will expand to 20 mln annually
CreateTime:2011-09-13     Source:ResearchInChina Editor:hangmei
Text Size:       
Changshan Biochemical Pharmaceutical (hereafter referred as CSBIO) was listed in Shenzhen Stock Exchange on 19 Aug. 2011, with registered capital of RMB110 million. Heparin Sodium BPC is the core p...
Forget password? get password
Welcome to our website.
This service is open to member only.

Contact our customer service team
Tel: 86-10-82600828, 82601561
Email: report@researchinchina.com

Related Reports
China Animal Vaccine Industry Report, 2019-2025
China Blood Product Industry Report, 2020-2026
China Vacuum Blood Collection Device Industry Report, 2019-2025
China Human Vaccine Industry Report, 2019-2025
China Independent Clinical Laboratory Industry Report, 2019-2025
2005-2021 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1